Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis

OBJECTIVE: Multiple sclerosis (MS) is the most common disabling neurological disease of young adults. The pathophysiological mechanism of MS remains largely unknown and no cure is available. Current clinical treatments for MS modulate the immune system, with the rationale that autoimmunity is at the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Transl Neurol
Egile Nagusiak: Zhai, Dongxu, Lee, Frankie H F, D'Souza, Cheryl, Su, Ping, Zhang, Shouping, Jia, Zhengping, Zhang, Li, Wong, Albert H C, Liu, Fang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402084/
https://ncbi.nlm.nih.gov/pubmed/25909084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.182
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak